Unknown PHASE2 INTERVENTIONAL 1-arm NCT01318889

Dexpanthenol Mouthwash to Treat Oral Mucositis

Effects of Topical Dexpanthenol on Chemotherapy and Radiotherapy Induced Oral Mucositis

Sponsor: Shahid Beheshti University of Medical Sciences

Conditions Oral Mucositis (Ulcerative) Due to Radiation

Updated 6 times since 2017 Last updated: Jul 5, 2011 Started: Sep 30, 2010 Primary completion: Sep 30, 2011 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01318889, this PHASE2 trial focuses on Oral Mucositis (Ulcerative) Due to Radiation and remains ongoing. Sponsored by Shahid Beheshti University of Medical Sciences, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shahid Beheshti University of Medical Sciences

Data source: Shahid Beheshti University of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tehran, Iran